Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Observe Medical ASA's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 63.62.
Observe Medical ASA's Days Inventory for the
six
months ended in Dec. 2025 was 186.69.
Observe Medical ASA's Days Payable for the
six
months ended in Dec. 2025 was 614.77.
Therefore, Observe Medical ASA's Cash Conversion Cycle (CCC) for the
six
months ended in Dec. 2025 was -364.46.
Observe Medical ASA (OSL:OBSRV) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Observe Medical ASA Cash Conversion Cycle Related Terms
Observe Medical ASA Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Observe Medical ASA's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:OBSRV vs ABT, SYK, MDT: Cash Conversion Cycle Comparison
For the Medical Devices subindustry, Observe Medical ASA's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Observe Medical ASA Cash Conversion Cycle vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Observe Medical ASA's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Observe Medical ASA's Cash Conversion Cycle falls into.
Observe Medical ASA Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Observe Medical ASA's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Conversion Cycle of -364.46 mean?
Observe Medical ASA (OSL:OBSRV) has a Cash Conversion Cycle of -364.46 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Observe Medical ASA and its competitors.
Is Observe Medical ASA's Cash Conversion Cycle too high?
Observe Medical ASA's current Cash Conversion Cycle is -364.46. Overall, Observe Medical ASA has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Observe Medical ASA's Cash Conversion Cycle compare to ABT and SYK?
Observe Medical ASA's Cash Conversion Cycle of -364.46 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash Conversion Cycle is 158.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Devices & Instruments company?
The median Cash Conversion Cycle among Medical Devices & Instruments companies is 158.96, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Observe Medical ASA and its competitors. For the Medical Devices & Instruments industry, the median Cash Conversion Cycle is 158.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Observe Medical ASA's current Cash Conversion Cycle is -364.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Observe Medical ASA stock overvalued right now?
Based on GuruFocus' analysis, Observe Medical ASA (OSL:OBSRV) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.29, compared to a current price of kr1.09 — trading 274.1% above its estimated fair value. The current Cash Conversion Cycle is -364.46. Observe Medical ASA's overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Observe Medical ASA (OSL:OBSRV), the current Cash Conversion Cycle is -364.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Observe Medical ASA (OSL:OBSRV) Overvalued in 2026?
Based on GuruFocus' analysis, Observe Medical ASA stock appears to be overvalued.
The current stock price of kr1.09 is trading 274.1% above its estimated GF Value™ of kr0.29.
GuruFocus considers Observe Medical ASA to be Significantly Overvalued.
Key valuation signals for OSL:OBSRV:
Cash Conversion Cycle: -364.46
GF Value™: kr0.29 vs. price of kr1.09 (274.1% above fair value)
No single metric tells the full story. See the OSL:OBSRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.
31GF Score
Get the complete analysis for OSL:OBSRV
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:OBSRV has been successfully added to your 
